Point72 Asset Management
LEGN icon

Point72 Asset Management’s Legend Biotech LEGN Stock Holding History

Point72 Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.8M Sell
3,076,124
-809,893
-21% -$21.8M 0.1% 237
2026
Q1 		$70.3M Buy
3,886,017
+1,101,211
+40% +$21M 0.09% 257
2025
Q4 		$60.5M Buy
+2,784,806
New +$79.8M 0.07% 332
2025
Q3 		– Sell
-227,906
Closed -$8.09M – 2517
2025
Q2 		$8.09M Buy
+227,906
New +$7.39M 0.02% 817
2024
Q4 		– Sell
-195,371
Closed -$9.52M – 2273
2024
Q3 		$9.52M Sell
195,371
-109,149
-36% -$5.81M 0.02% 662
2024
Q2 		$13.5M Buy
+304,520
New +$14M 0.04% 512
2022
Q4 		– Sell
-107,000
Closed -$4.37M – 1671
2022
Q3 		$4.37M Sell
107,000
-105,900
-50% -$4.97M 0.02% 760
2022
Q2 		$11.7M Buy
+212,900
New +$8.99M 0.05% 473
2021
Q2 		– Sell
-1,639,200
Closed -$47.6M – 1078
2021
Q1 		$47.6M Buy
+1,639,200
New +$44.7M 0.22% 116

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's LEGN Position: Q2 2026 in Review

Point72 Asset Management reduced its Legend Biotech (LEGN) stake by 21% in Q2 2026, selling an estimated $21.8M and leaving 3,076,124 shares worth $88.8M. The position accounts for 0.1% of the portfolio, ranked #237.

Point72 Asset Management first reported a position in LEGN in Q1 2021 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Point72 Asset Management held 3,076,124 shares of Legend Biotech worth $88.8M as of Q2 2026.
  • Point72 Asset Management sold 809,893 Legend Biotech shares in Q2 2026, an estimated $21.8M.
  • Legend Biotech made up 0.1% of Point72 Asset Management's portfolio in Q2 2026, its #237 holding.
  • Point72 Asset Management first reported a position in Legend Biotech in Q1 2021 and has held it in 9 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.